<DOC>
	<DOCNO>NCT00191048</DOCNO>
	<brief_summary>The purpose study assess efficacy safety atomoxetine administer daily treatment child adolescent ADHD comorbid dyslexia .</brief_summary>
	<brief_title>Treatment With Atomoxetine Hydrochloride Children Adolescents With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Dyslexia</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Patients ADHD ADHD Dyslexia At least 10 year old 16 year old IQ score 80 Must able swallow capsule Have receive treatment within last 30 day drug receive regulatory approval indication time study entry Weigh le 25 kg great 70 kg Pregnant breast feeding Documented history bipolar I II disorder , psychosis Documented history autism , Asperger 's syndrome pervasive developmental disorder</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>